Article info

Download PDFPDF

NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade
Free

Authors

  1. a frederick.kohlhapp{at}rutgers.edu
  2. b joebroucek{at}gmail.com
  3. c Tasha_Hughes{at}rush.edu
  4. d erica.j.huelsmann{at}gmail.com
  5. e j.lusciks{at}gmail.com
  6. f janetzayas01{at}gmail.com
  7. g hdolubizno{at}gmail.com
  8. h vidyaratna_a_fleetwood{at}rush.edu
  9. i yo.alisagrin{at}gmail.com
  10. j graham.hilldo{at}gmail.com
  11. k josephposhepny{at}gmail.com
  12. l nabatiyan{at}gmail.com
  13. m carl.ruby{at}yahoo.com
  14. n snook5029{at}gmail.com
  15. o jarudra{at}UTMB.EDU
  16. p jasonschenkel2007{at}u.northwestern.edu
  17. q masopust{at}umn.edu
  18. r andrew.zloza{at}rutgers.edu
  19. s howard.kaufman{at}rutgers.edu
View Full Text

Citation

Kohlhapp FJ, Broucek JR, Hughes T, et al
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade

Publication history

  • Received March 9, 2015
  • Accepted April 17, 2015
  • First published May 19, 2015.
Online issue publication 
February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.